Thus, depending on AD disease phenotype, the novel factors we detail demonstrated effects that were independent of, or synergistic with, APOE ɛ4 mechanisms of disease, highlighting their distinct relevance to AD risk modeling. The gene discussed is APOE; the disease is Alzheimer disease.